欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
NL/H/1092/001
药品名称
Vincristinesulfaat Teva 1 mg/ml
活性成分
vincristine sulfate 1.0 mg/ml
剂型
Solution for injection
上市许可持有人
Teva B.V., Haarlem, The Netherlands
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Germany (DE)
Vincistinesulfat 1 mg / ml Injektionslösung
United Kingdom (Northern Ireland) (XI)
France (FR)
Italy (IT)
Poland (PL)
Latvia (LV)
Lithuania (LT)
Vincristine Teva 1 mg/ml injekcinis tirpalas
Czechia (CZ)
Vincristin-Teva 1 mg/ml injekční roztok
许可日期
2008/05/26
最近更新日期
2024/04/10
药物ATC编码
L01CA02 vincristine
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final PL
|
Vincristin_NL_H_1092_001_PIL_25_10_22
Date of last change:2022/11/24
Final SPC
|
Vincristin_NL_H_1092_001_SmPC_25_10_22
Date of last change:2022/11/24
Final Labelling
|
common-spc-clean
Date of last change:2015/04/30
Final Labelling
|
common-pl-clean
Date of last change:2015/04/30
Final Labelling
|
common-interpack-clean
Date of last change:2015/04/30
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase